A detailed history of Profund Advisors LLC transactions in Inhibrx, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 31,335 shares of INBX stock, worth $444,016. This represents 0.04% of its overall portfolio holdings.

Number of Shares
31,335
Previous 17,124 82.99%
Holding current value
$444,016
Previous $650,000 68.46%
% of portfolio
0.04%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$32.76 - $39.56 $465,552 - $562,187
14,211 Added 82.99%
31,335 $1.1 Million
Q4 2023

Feb 14, 2024

SELL
$14.5 - $38.0 $38,019 - $99,636
-2,622 Reduced 13.28%
17,124 $650,000
Q3 2023

Nov 13, 2023

SELL
$15.75 - $26.31 $69,441 - $116,000
-4,409 Reduced 18.25%
19,746 $362,000
Q2 2023

Aug 10, 2023

SELL
$16.96 - $27.82 $78,762 - $129,196
-4,644 Reduced 16.13%
24,155 $627,000
Q1 2023

May 11, 2023

BUY
$18.45 - $27.14 $531,341 - $781,604
28,799 New
28,799 $543,000

Others Institutions Holding INBX

About Inhibrx, Inc.


  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $553M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.